Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001824293-24-000138
Filing Date
2024-09-11
Accepted
2024-09-11 16:36:50
Documents
16
Period of Report
2024-09-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K/A val-20240910.htm   iXBRL 8-K/A 23011
6 val-20240910_g1.jpg GRAPHIC 16879
7 val-20240910_g2.jpg GRAPHIC 1656
  Complete submission text file 0001824293-24-000138.txt   191440

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT val-20240910.xsd EX-101.SCH 2166
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT val-20240910_def.xml EX-101.DEF 3313
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT val-20240910_lab.xml EX-101.LAB 24438
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT val-20240910_pre.xml EX-101.PRE 15215
18 EXTRACTED XBRL INSTANCE DOCUMENT val-20240910_htm.xml XML 2822
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40034 | Film No.: 241293046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)